France And Montréal


SURESNES, France and MONTRAL, November 8, 2011 - Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada(Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment.
Older News
S M T W T F S
23 24 25 26 27 28 29
30 31 1 2 3 4 5
6 7 8 9 10 11 12
Copyright© 2011 The Gaea Times